Lymphoid neoplasm
MONDO:0005157A neoplasm composed of a lymphocytic cell population which is usually malignant (clonal) by molecular genetic and/or immunophenotypic analysis. Lymphocytic neoplasms include Hodgkin and non-Hodgkin lymphomas, acute and chronic lymphocytic leukemias, and plasma cell neoplasms.
Also known as: lymphocytic and plasma cell neoplasm, lymphocytic and plasma cell tumor, lymphocytic and plasma cell tumour, lymphocytic and plasmacytic neoplasm, lymphocytic neoplasm, lymphocytic tumor, lymphocytic tumour, lymphoid and plasma cell tumor
5948 clinical trials for this condition and its sub-types, 11 tagged with Lymphoid neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Lymphoid neoplasm
-
Lymphoma 606 trials · 4,243 incl. sub-types
27 sub-types
- B-cell neoplasm 304 trials · 3,167 incl. sub-types Sub-types →
- Non-Hodgkin lymphoma 526 trials · 2,897 incl. sub-types Sub-types →
- Primary organ-specific lymphoma 0 trials · 329 incl. sub-types Sub-types →
- Hodgkins lymphoma 262 trials · 326 incl. sub-types Sub-types →
- Mediastinal malignant lymphoma 6 trials · 180 incl. sub-types Sub-types →
- Pediatric lymphoma 3 trials · 141 incl. sub-types Sub-types →
- Peripheral T-cell lymphoma, not otherwise specified 61 trials
- Extranodal nasal NK/T cell lymphoma 51 trials
- Adult lymphoma 1 trial · 33 incl. sub-types Sub-types →
- Eye lymphoma 0 trials · 16 incl. sub-types Sub-types →
- B-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical Hodgkin lymphoma 11 trials · 12 incl. sub-types Sub-types →
- Gastrointestinal lymphoma 0 trials · 7 incl. sub-types Sub-types →
- Composite lymphoma 5 trials
- AIDS-related primary central nervous system lymphoma 3 trials
- Breast lymphoma 0 trials · 1 incl. sub-types Sub-types →
- Heart lymphoma 1 trial
- Bladder lymphoma 0 trials
- Chest wall lymphoma 0 trials Sub-types →
- Lung lymphoma 0 trials Sub-types →
- Methotrexate-associated lymphoproliferative disorders 0 trials
- Nasal cavity lymphoma 0 trials
- Ovarian lymphoma 0 trials
- Progressive transformation of germinal centers 0 trials
- Prostate lymphoma 0 trials
- Retroperitoneal lymphoma 0 trials
- Tracheal lymphoma 0 trials
- Ureteral lymphoma 0 trials
-
Lymphoid leukemia 23 trials · 1,360 incl. sub-types
3 sub-types
- Acute lymphoblastic leukemia 507 trials · 1,317 incl. sub-types Sub-types →
- T-cell leukemia 9 trials · 137 incl. sub-types Sub-types →
- T-cell large granular lymphocyte leukemia 18 trials
-
Precursor lymphoblastic lymphoma/leukemia 12 trials · 1,342 incl. sub-types
4 sub-types
- Acute lymphoblastic leukemia 507 trials · 1,317 incl. sub-types Sub-types →
- Lymphoblastic lymphoma 78 trials · 104 incl. sub-types Sub-types →
- T lymphoblastic leukemia/lymphoma 18 trials · 100 incl. sub-types Sub-types →
- B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality 0 trials · 59 incl. sub-types Sub-types →
-
Neoplasm of immature B and T cells 0 trials · 1,317 incl. sub-types
1 sub-type
- Acute lymphoblastic leukemia 507 trials · 1,317 incl. sub-types Sub-types →
-
T-cell and NK-cell neoplasm 8 trials · 324 incl. sub-types
2 sub-types
- Neoplasm of mature T-cells or NK-cells 4 trials · 248 incl. sub-types Sub-types →
- T lymphoblastic leukemia/lymphoma 18 trials · 100 incl. sub-types Sub-types →
-
Malignant lymphatic vessel tumor 0 trials
Most studied deeper sub-types
-
New stem cell filter could cut transplant complications in blood cancer patients
Disease control Recruiting nowThis early-phase study tests a new automated method (CliniMACS Prodigy) to select CD34 stem cells for patients with blood cancers who need a stem cell boost or second transplant. The goal is to reduce the risk of severe graft-versus-host disease (GVHD) while improving blood cell …
Phase 1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Experimental drug BL-M08D1 takes on recurrent lymphoid cancers
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called BL-M08D1 in 22 adults with relapsed or refractory lymphoid malignancies (cancers of the lymph system that have come back or not responded to treatment). The drug is given by IV every 3 weeks. The main goals are to chec…
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Scientists collect samples to unlock secrets of lymphoid cancers
Knowledge-focused Recruiting nowThis study collects blood, urine, bone marrow, and tissue samples from over 1,200 adults with lymphoid cancers or precancerous conditions. The goal is to help researchers better understand cancer biology, which may lead to new methods for diagnosing or treating these diseases. No…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can a simple test predict CAR t success? new study hopes to find out
Knowledge-focused Recruiting nowThis study is testing a new combination of blood tests, scans, and health checks to see if it can predict which lymphoma patients will respond well to CAR T cell therapy. Researchers will follow 50 patients with relapsed or hard-to-treat B-cell lymphoma who are already scheduled …
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC